Federal grants to Insoma Bio, Inc.
Insoma Bio, Inc. in Durham, North Carolina received $5.1 million in federal grants from fiscal 2021 to 2025, across 7 awards. Its largest program was Cancer Biology Research, with $2.0 million. In fiscal 2025 it was awarded $693,868.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$5.1 million
- Awards7
- Awarded in FY 2025$693,868
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $543,760 |
| FY 2022 | 1 | $936,817 |
| FY 2023 | 3 | $2.3 million |
| FY 2024 | 2 | $590,134 |
| FY 2025 | 1 | $693,868 |
Programs that fund Insoma Bio, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cancer Biology Research | 1 | $2.0 million |
| Technology, Innovation, and Partnerships | 1 | $1.7 million |
| Biomedical Research and Research Training | 2 | $576,356 |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $296,151 |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $290,768 |
| Engineering | 1 | $252,992 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $3.1 million |
| National Science Foundation | 2 | $1.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A recombinant matrix to improve autologous tissue grafts - project summary the objective of this proposal is to further develop a new restorative tissue matrix which phase i studies indicate is capable of expanding the utility of autologous fat grafting in breast reconstructive surgery. This objecti | Cancer Biology Research | June 24, 2022 | $2.0 million |
| Sbir phase II: an injectable protein matrix to enhance the stability of autologous fat grafts -the broader impact of this small business innovation and research (SBIR) phase II project will improve clinical outcomes for the thousands of patients globally who undergo craniofacial repair surgery each | Technology, Innovation, and Partnerships | August 23, 2023 | $1.7 million |
| Enhancing peripheral nerve repair with an injectable recombinant polypeptide scaffold - project summary the objective of this proposal is to investigate the ability of an injectable polypeptide scaffold -- insoma bio’s proprietary elastin-derived biomaterial fractomertm -- to improve outcomes after | Extramural Research Programs in the Neurosciences and Neurological Disorders | August 1, 2024 | $296,151 |
| An off the shelf alternative to fat transfer for soft tissue repair - project summary the goal of this phase i sbir program is the development of an optimized, off-the-shelf alternative to autologous fat grafting for soft tissue repair. Fat grafting is commonly used as a minimally invasive alternati | Biomedical Research and Research Training | August 16, 2024 | $293,983 |
| Fully defined matrices for organoid culture - project summary compared to standard two dimensional methods, three dimensional cell culture presents an opportunity to more reliably replicate and model in vivo physiology under controlled laboratory conditions. Organoid culture in particular has been s | Diabetes, Digestive, and Kidney Diseases Extramural Research | September 20, 2021 | $290,768 |
| A recombinant elastin skin substitute for the treatment of burns - project summary the goal of this project is to optimize and evaluate insoma bio’s proprietary recombinant elastin-based biomaterial, fractomer®, as an effective, low-cost skin grafting support matrix for the treatment of severe burn | Biomedical Research and Research Training | March 31, 2023 | $282,373 |
| Sbir phase i: an injectable protein matrix to enhance the stability of autologous fat grafts | Engineering | July 6, 2021 | $252,992 |
Questions people ask
How much federal grant money does Insoma Bio, Inc. get?
$5.1 million in 7 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Insoma Bio, Inc. the most?
The Department of Health and Human Services, with $3.1 million in 5 awards. The National Science Foundation follow.
What is Insoma Bio, Inc.'s largest federal grant?
$2.0 million under Cancer Biology Research, with its first action in the period on June 24, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Insoma Bio, Inc.?
Its largest are Cancer Biology Research, Technology, Innovation, and Partnerships and Biomedical Research and Research Training.
Other grant recipients in Durham
- Duke University
- Family Health International
- North Carolina Central University
- Housing Authority of the City of Durham
- Rho Federal Systems Division Inc
- City of Durham
- Families & Communities Rising, Inc.
- Lincoln Community Health Center Incorporated
Largest federal grant recipients in North Carolina · Federal grants in North Carolina